Log In
Print this Print this

emodepside (BAY 44-4400)

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionSemi-synthetic antihelminthic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Infectious (unspecified)
Indication DetailsTreat onchocerciasis
Regulatory Designation
PartnerBayer AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today